Chronic 3,4-methylenedioxymethamphetamine administration decreases glucocorticoid and mineralocorticoid receptor, but increases 5-hydroxytryptamine1c receptor gene expression in the rat hippocampus

This publication has 50 references indexed in Scilit:

• Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors
  Neuropharmacology, 1992
• 5-HTIC receptors mediate phosphoinositide turnover activation in the immature rat hippocampus
  European Journal of Pharmacology: Molecular Pharmacology, 1992
• Psychiatric illness associated with "ecstasy"
  The Lancet, 1991
• Central 5,7‐Dihydroxytryptamine Lesions Decrease Hippocampal Glucocorticoid and Mineralocorticoid Receptor Messenger Ribonucleic Acid Expression
  Journal of Neuroendocrinology, 1990
• Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations^a
  Annals of the New York Academy of Sciences, 1990
• Role of Serotonin in Depression^a
  Annals of the New York Academy of Sciences, 1990
• Distribution of serotonin 5‐HT_1C receptor mRNA in adult rat brain
  FEBS Letters, 1989
• Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate Campus
  New England Journal of Medicine, 1987
• Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine
  Molecular and Cellular Endocrinology, 1983
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976